Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isothiazole dioxides as CXC- and CC-chemokine receptor ligands

Isothiazole dioxides as CXC- and CC-chemokine receptor ligands

US Patent 7671212 · Granted Mar 2, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflamma2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
Hormone receptor modulators for treating metabolic conditions and disorders2025
Cyclic pantetheine derivatives and uses thereof2024
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors2023
Hormone receptor modulators for treating metabolic mutagenic and fibrotic condit2023
Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators2023
Pharmaceutical formulations that form gel in situ2023
Pyrimidine JAK inhibitors for the treatment of skin diseases2022
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors2021
Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators2021
Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,2021